EAT is up +49.38%% since April’24 pick View All Top Buy Picks
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ZEAL.CO
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Zealand Pharma A/S stock downgraded from Buy Candidate to Hold/Accumulate after Friday trading session.
(Updated on Jun 28, 2024)

Buy or Hold candidate since Jun 26, 2024 Gain 2.18% PDF

The Zealand Pharma A/S stock price gained 2.65% on the last trading day (Friday, 28th Jun 2024), rising from kr869.50 to kr892.50. During the last trading day the stock fluctuated 4.09% from a day low at kr880.00 to a day high of kr916.00. The price has been going up and down for this period, and there has been a 34.72% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 379 thousand more shares were traded than the day before. In total, 707 thousand shares were bought and sold for approximately kr631.17 million.

The stock has broken the wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at kr745.61, a level that may pose a second chance to hit a runner.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ZEAL.CO Signals & Forecast

The Zealand Pharma A/S stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at kr821.29 and kr670.29. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 12, 2024, and so far it has risen 45.95%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation

Support, Risk & Stop-loss for Zealand Pharma A/S stock

Zealand Pharma A/S finds support from accumulated volume at kr873.50 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved kr36.00 between high and low, or 4.09%. For the last week, the stock has had daily average volatility of 5.29%.

The Zealand Pharma A/S stock is extremely overbought on RSI14 (77). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: kr861.62 (-3.46%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 77 and this increases the risk substantially. There is a buy signal from a pivot bottom found 34 days ago.)

Trading Expectations (ZEAL.CO) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Zealand Pharma A/S to open at kr896.17, and during the day (based on 14 day Average True Range), to move between kr850.61 and kr934.39, which gives a possible trading interval of +/-kr41.89 (+/-4.69%) up or down from last closing price. If Zealand Pharma A/S takes out the full calculated possible swing range there will be an estimated 9.39% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ kr873.50, some kr19.00 (2.13%) from the current price of kr892.50, our system finds the risk reward attractive.

Is Zealand Pharma A/S stock A Buy?

Zealand Pharma A/S holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Zealand Pharma A/S of Monday, July 1, 2024

Fair opening price July 1, 2024 Current price
kr896.17 ( 0.411%) kr892.50

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ZEAL.CO

Fibonacci Support & Resistance Levels

Level Price
R3 932.17 4.44%
R2 918.41 2.90%
R1 909.92 1.95%
Price 892.50
S1 882.41 -1.13%
S2 873.92 -2.08%
S3 860.17 -3.62%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 892.50
S1 873.50 -2.13%
S2 811.00 -9.13%
S3 767.50 -14.01%

FAQ

What is the symbol for Zealand Pharma A/S Stock and on which exchange is it traded?
The symbol for Zealand Pharma A/S is ZEAL.CO and it is traded on the OMXC (Copenhagen Stock Exchange).

Should I buy or sell Zealand Pharma A/S Stock?
Zealand Pharma A/S holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Zealand Pharma A/S Stock?
Zealand Pharma A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Zealand Pharma A/S Stock.

What's the current price of Zealand Pharma A/S Stock?
As of the end of day on the Jun 28, 2024, the price of an Zealand Pharma A/S (ZEAL.CO) share was kr892.50.

What is the 52-week high and low for Zealand Pharma A/S Stock?
The 52-week high for Zealand Pharma A/S Stock is kr916.00 and the 52-week low is kr212.20.

What is the market capitalization of Zealand Pharma A/S Stock?
As of the Jun 28, 2024, the market capitalization of Zealand Pharma A/S is 55.602B.

When is the next earnings date for Zealand Pharma A/S?
The upcoming earnings date for Zealand Pharma A/S is Aug 15, 2024.
Click to get the best stock tips daily for free!

About Zealand Pharma A/S

Zealand Pharma A/S Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin and Lyxumia; Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hy... ZEAL.CO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT